Psyzone Research
The Largest Unified Research Database on Psychedelics & Endogenous Substances
Access peer-reviewed scientific literature on psychedelic substances, their therapeutic applications, and clinical outcomes.
Support Independent Research
Help us keep this database free and accessible to everyone.
Why Research Matters
Public information about psychedelics is often fragmented, sensationalized, or misinterpreted. Many people form opinions without understanding the current state of scientific evidence. Psyzone Research is designed to help you understand what is actually happening in science — beyond headlines, trends, or misinformation.
We provide curated scientific studies, contextual explanations, and structured access to knowledge — bridging the gap between academic research and real-world understanding.
What Research Provides
Curated Insights
Carefully selected studies from leading institutions and peer-reviewed publications, organized for clarity and accessibility.
Accessible Knowledge
Complex scientific research translated into understandable language, making evidence-based information available to everyone.
Evolving Evidence
Continuous tracking of emerging scientific evidence as new studies are published and clinical understanding develops.
Clinical Research Focus
Areas being studied in clinical research — including depression, anxiety, PTSD, resilience, and mental health — presented with scientific rigor.
Global Clinical Trials
Tracking clinical trials is one of the most concrete ways to understand the real progress of psychedelic science. Each trial represents an institution, a research question, and a commitment to rigorous methodology. The map below shows where this work is happening — a landscape that continues to evolve as new studies are registered and completed.
Clinical trials data sourced from ClinicalTrials.gov. The results of clinical trials suggest that psychedelics could be used for a range of therapeutic purposes, but understanding the current research landscape can be complex. This map, featuring data from ClinicalTrials.gov, provides a way to navigate past, ongoing, and future trials.
Loading map...
Latest High-Impact Research
View All PapersPsilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations.
Psilocybin, a classic psychedelic compound, has garnered renewed interest as a potential treatment for various psychiatric disorders. This review provides a comprehensive overview of psilocybin's hist...
Psychedelic medicine: mechanisms, evidence, and translation to practice
Over the past 15 years, psychedelic treatments have garnered substantial clinical interest, with psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) advancing to phase 3 trials for various psychia...
Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource
ImportanceDepression is a major cause of disability worldwide, motivating substantial interest in psilocybin as a potential treatment. ObjectiveTo conduct a systematic review and meta-analysis of psil...
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder of Mode...
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder ...